Invasive ductal carcinoma (1009 cases) | Invasive lobular carcinoma (130 cases) | Ductal carcinoma in situ (459 cases) | |
---|---|---|---|
Calcium channel blockers | |||
Never used | Reference | Reference | Reference |
Former user | 1.05 (0.59–1.86) | 1.68 (0.41–6.85) | 0.98 (0.41–2.38) |
Current user (<5 years) | 0.66 (0.45–0.97) | 2.26 (1.12–4.55) | 0.78 (0.46–1.35) |
(5–10 years) | 1.05 (0.66–1.66) | 1.13 (0.28–4.61) | 1.28 (0.68–2.41) |
(10+ years) | 0.80 (0.45–1.42) | 0.69 (0.10–4.99) | 0.80 (0.33–1.94) |
All antihypertensives | |||
Never used | Reference | Reference | Reference |
Former user | 1.03 (0.69–1.53) | 0.30 (0.04–2.16) | 1.15 (0.66–2.01) |
Current user (<5 years) | 0.90 (0.74–1.08) | 0.88 (0.51–1.50) | 1.06 (0.82–1.39) |
(5–10 years) | 0.97 (0.77–1.22) | 1.21 (0.65–2.24) | 0.87 (0.60–1.26) |
(10+ years) | 0.94 (0.74–1.19) | 0.57 (0.24–1.34) | 0.88 (0.60–1.28) |